Directory
>
Ann Gelormini
Ann Gelormini
Vice President, Pharmaceutical Development & Manufacturing | Deciphera Pharmaceuticals
Waltham, Massachusetts, United States
Ann Gelormini
Summary
Ann Gelormini is a seasoned CMC professional with extensive experience in pharmaceutical development and manufacturing, currently serving as Vice President at Deciphera Pharmaceuticals. With a strong background in both big pharma and biotech, she has successfully managed cross-functional teams and multiple projects across various stages of drug development. Ann's expertise lies in CMC activities, from preclinical through to commercialization, making her a key player in the industry. She is known for her ability to navigate complex regulatory environments and her strong technical skills in organic chemistry and analytical sciences. Her leadership has been instrumental in advancing several clinical candidates, including ripretinib. Ann holds a Ph.D. in Chemistry from Case Western Reserve University and has completed post-doctoral research at Harvard University. Her commitment to innovation and collaboration continues to drive her career forward.
Ann Gelormini
Work Experience
Vice President, Pharmaceutical Development & Manufacturing at
Deciphera Pharmaceuticals
April 2024 - Present
Vice President, Chemical Development & Manufacturing at
Deciphera Pharmaceuticals
January 2022 - April 2024
Sr. Director, Manufacturing Sciences & Technology at
Deciphera Pharmaceuticals
March 2019 - December 2021
Director, Chemistry, Manufacturing, and Controls at
Ocular Therapeutix, Inc.
January 2017 - March 2019
Director, Chemistry, Manufacturing, and Controls at
Entasis Therapeutics
January 2015 - January 2017
Director, Drug Process Development at
AEGERION PHARMACEUTICALS LIMITED
January 2012 - January 2015
Manager, Chemical Process Development at
Aegerion Pharma
January 2012 - January 2012
Manager, Chemical Development at
Dogwood Pharmaceuticals A Subsidiary Of Forest Labs
January 2010 - January 2012
Principal Research Investigator at
Sanofi
January 2002 - January 2010
Sr. Scientist at
Johnson & Johnson
January 1999 - January 2002
Ann Gelormini
Education
January 1996
Harvard University, Post-Doc
January 1997 - January 1999
Case Western Reserve University, Ph.D.
January 1991 - January 1996
Case Western Reserve University, Bachelor Of Science In Chemistry
January 1987 - January 1991
Frequently Asked Questions about Ann Gelormini
What is Ann Gelormini email address?
Ann Gelormini's primary email address is **********@deciphera.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ann Gelormini work for?
Ann Gelormini is a Vice President, Pharmaceutical Development & Manufacturing at Deciphera Pharmaceuticals, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Ann Gelormini graduated from?
Ann Gelormini holds a degree in Exchange Visiting Post Doctoral Fellow With Prof. Ian Fleming from Amridge University.
How can I directly contact Ann Gelormini?
To contact Ann Gelormini directly, you can use the email address **********@deciphera.com. Complete contact information is available upon registration with Muraena.
Who is Ann Gelormini?
Ann Gelormini is a seasoned CMC professional with extensive experience in pharmaceutical development and manufacturing, currently serving as Vice President at Deciphera Pharmaceuticals. With a strong background in both big pharma and biotech, she has successfully managed cross-functional teams and multiple projects across various stages of drug development. Ann's expertise lies in CMC activities, from preclinical through to commercialization, making her a key player in the industry. She is known for her ability to navigate complex regulatory environments and her strong technical skills in organic chemistry and analytical sciences. Her leadership has been instrumental in advancing several clinical candidates, including ripretinib. Ann holds a Ph.D. in Chemistry from Case Western Reserve University and has completed post-doctoral research at Harvard University. Her commitment to innovation and collaboration continues to drive her career forward.
Ann`s contact details
**********@deciphera.com
***********@att.net
Colleagues
VP, Head of Commercial International & Iberia GM
VP, Quality Assurance
Vice President
Vice President, Head of Biometrics
Senior Vice President, US Commercial
VP of Chemistry and Preclinical Development
Executive Director and Head of Global Medical Writing & Clinical Trial Disclosure
Executive Director, Clinical Operations
VP, Head of Pharmacovigilance
General Manager DACH